Summit Veterinary Pharmaceuticals Ltd

The animal health company Swedencare has today, April 1, completed the acquisition of British Summit Veterinary Pharmaceuticals, an acquisition announced on March 24. This is stated in a press release. The purchase price of GBP 30 million is paid through a cash payment of GBP 27 million and through a non-cash issue of 978,119 shares in Swedencare valued at GBP 3 million. Swedencare then has 159.84 million shares outstanding. A potential earn-out of up to £15 million may be payable if certain conditions are met by April 1, 2027.